Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • INTU vs MRNA✓SelectedUSD · MRNAINTU vs MRNA performance historyLatest closeAs of-2.35%11/18
Stock and ETF performance explorer

INTU vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+64.4%
MRNA return
+794.5%
Excess return
-730.1%
Maximum drawdown
-68.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.4%-4.8%+2.5%-2.1%
7D-8.6%-20.9%+12.3%-7.4%
30D-3.8%-13.3%+9.5%-3.3%
3M-10.2%+212.6%-222.8%-20.2%
6M-21.6%+309.0%-330.6%-32.5%
YTD-52.0%+567.3%-619.4%-61.0%
1Y-51.1%+689.7%-740.8%-61.0%
3Y-42.6%+157.4%-200.0%-51.0%
5Y-48.2%-21.7%-26.4%-52.2%
All+64.4%+794.5%-730.1%+30.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling